2VERMA A, NATALE A. Should atrial fibrillion ablation be considered first-line therapy for some patiants? Why atrial fibrillation ablation should be considered first-line therapy for some patients [ J ]. Circulation, 2005, 112 (8) : 1214-1222.
3CORLEY S D, EPSTEIN A E, DIMARCO J P, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investgation of Rhythm Management (AFFIRM) study [ J] . Circulation, 2004, 109 (12): 1509-1513.
4NADEMANEE K, MCKENZIE J, KOSAR E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate [ J]. J Am Coll Cardiol, 2004, 43 ( 11 ) : 2044-2053.
5JAIS P, CAUCHEMEZ B, MACLE L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study[J]. Circulation, 2008, 118 (24) : 2498 -2505.
6KHAN M N, JAYS P, CUMMINGS J, et al. Pulmonaryvein isolation for atrial fibrillation in patients with heart failure[J]. N Engl J Med, 2008, 359 (17) : 1778- 1785.
7CAPPATO R, CALKINS H, CHEN S A, et ah Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[ J]. Cilvulation, 2005, 111 (9): 1100-1105.
8FUSTER V, RYDEN L E, CANNOM D S, et al. ACC/ AHA/ESC 2006 guideline for the management of pa- tients with atrial fibrillation: ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation ) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[ J]. Circulation, 2006, 114(7) : e257-e354.
9ORAl. H, CHUGH A, OZYADIN M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation for atrial fibrillation [ J ]. Circulation, 2006, 114 (8): 759-765.
10SHERMAN D G. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control[ J]. Stroke, 2007, 38 (2s): 615-617.
10COX J L, SCHUESSLER R B, BOtNEAU J P, et al. The development of the maze procedure for the treatment of atrial fibrillation [J]. Semin Thorae Cardiovase Surg, 2000, 12 (1) : 2-14.
